Background: Cancer genetic counseling and testing is a standard of care option for appropriate families and can identify individuals at increased risk prior to diagnosis, when prevention or detection strategies are most effective. Despite documented efficacy of cancer risk reduction in high-risk individuals, underserved and minority individuals have a disproportionate cancer burden and limited access to genetic counseling. Methods: A needs assessment survey documented gaps in knowledge and interest in prevention. Satellite clinics were established at two indigent healthcare systems. Cancer genetics CME lectures were conducted and referral guidelines disseminated to clinicians who referred patients for counseling. Results: An increase in clinician knowledge was demonstrated post-CME and reflected by quality referrals. Eighty-eight percent of patients kept their appointments. In the predominantly Latina6 (n=77) clinic population, 71.4% were affected with cancer, and 17 mutation positive families were identified. Preliminary data shows a positive impact on patients' motivation and behavior. The majority has expressed satisfaction and reduction in anxiety. Conclusions: This study demonstrates feasibility and acceptability of cancer genetics services in this population, suggesting the potential to reduce cancer morbidity in underserved, high-risk families.
Similar content being viewed by others
REFERENCES
ACS. (2003). Cancer Facts and Figures for Hispanics/Latinos 2003–2005 (No. 8623.00). Atlanta, GA: American Cancer Society.
Armstrong, K., Weber, B., Stopfer, J., Calzone, K., Putt, M., Coyne, J., et al. (2003). Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. Am J Med Genet A, 117, 154–160.
ASCO. (2003). American society of clinical oncology policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol, 21, 2397–2406.
Biffl, W. L., Myers, A., Franciose, R. J., Gonzalez, R. J., & Darnell, D. (2001). Is breast cancer in young Latinas a different disease? Am J Surg, 182, 596–600.
Blazer, K. R., MacDonald, D. J., Ricker, C., Sand, S., Uman, G. C., & Weitzel, J. N. (2005). Outcomes from intensive training in genetic cancer risk counseling for clinicians. Genet Med, 7, 40–47.
Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J., Lynch, P., et al. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. J Am Med Assoc, 277, 997–1003.
Castro, F. G., Furth, P., & Karlow, H. (1984). The health beliefs of Mexican, Mexican American, and Anglo American women. Hispanic J Behav Sci, 6, 365–383.
Claus, E. B., Risch, N., & Thompson, W. D. (1994). Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction. Cancer, 73, 643–651.
Croyle, R. T., & Lerman, C. (1999). Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr, 59–66.
Daly, M. B., Axibund, J. E., Bryant, E., Buys, S., Eng, C., Friedman, S., et al. (2006). Genetic/Familial high-risk assessment breast and ovarian. J Natl Compr Canc Netw, 4, 156–176.
Diez, O., Cortes, J., Domenech, M., Brunet, J., Del Rio, E., Pericay, C., et al. (1999). BRCA1 mutation analysis in 83 Spanish breast and breast/ovarian cancer families. Int J Cancer, 83, 465–469.
Eichmeyer, J. N., Northrup, H., Assel, M. A., Goka, T. J., Johnston, D. A., & Williams, A. T. (2005). An assessment of risk understanding in Hispanic genetic counseling patients. J Genet Couns, 14, 319–328.
Elledge, R. M., Clark, G. M., Chamness, G. C., & Osborne, C. K. (1994). Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst, 86, 705–712.
Ford, D., Easton, D. F., Bishop, D. T., Narod, S. A., Goldgar, D. E., & Consortium, T. B. C. L. (1994). Risks of cancer in BRCA1-mutation carriers. The Lancet, 343, 692–695.
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., et al. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet, 62, 676–689.
Frazier, E. L., Jiles, R. B., & Mayberry, R. (1996). Use of screening mammography and clinical breast examinations among black, Hispanic, and white women. Prev Med, 25, 118–125.
Gail, M. H., & Costantino, J. P. (2001). Validating and Improving Models for Projecting the Absolute Risk of Breast Cancer. J Natl Cancer Inst, 93, 334–335.
Gonzalez, J. T. (1990). Factors relating to frequency of breast self-examination among low-income Mexican American women. Implications for nursing practice. Cancer Nurs, 13, 134–142.
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., et al. (2001). Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst, 93, 1633–1637.
Hoffman, L. K. (2002). Race and cancer genetics: lessons from BRCA1. Oncology (Huntingt), 16, 108–112; discussion 113, 118–109.
Huerta, E. E., & Macario, E. (1999). Communicating health risk to ethnic groups: reaching Hispanics as a case study. J Natl Cancer Inst Monogr, 23–26.
Hughes, C., Gomez-Caminero, A., Benkendorf, J., Kerner, J., Isaacs, C., Barter, J., et al. (1997). Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns, 32, 51–62.
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., et al. (2002). Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med, 346, 1609–1615.
Lerman, C., Hughes, C., Benkendorf, J. L., Biesecker, B., Kerner, J., Willison, J., et al. (1999). Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev, 8, 361–367.
Lerman, C., Hughes, C., Lemon, S. J., Main, D., Snyder, C., Durham, C., et al. (1998). What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2 linked families who decline genetic testing. J Clin Oncol, 16, 1650–1654.
Liede, A., & Narod, S. A. (2002). Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat, 20, 413–424.
MacDonald, D. J., Sarna, L., Uman, G. C., Grant, M., & Weitzel, J. N. (2005). Health beliefs of women with and without breast cancer seeking genetic cancer risk assessment. Cancer Nurs, 28, 372–379.
Marin, G. (1989). AIDS prevention among Hispanics: needs, risk behaviors, and cultural values. Public Health Rep, 104, 411–415.
Marin, G., Sabogal, F., VanOss Marin, B., & Otero-Stable, E. (1987). Development of a Short Acculturation Scale for Hispanics. Hispanic J Behav Sci, 9, 183–203.
McDonnell, S. K., Schaid, D. J., Myers, J. L., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001). Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol, 19, 3938–3943.
McGarvey, E. L., Clavet, G. J., Johnson, J. B., 2nd, Butler, A., Cook, K. O., & Pennino, B. (2003). Cancer screening practices and attitudes: Comparison of low-income women in three ethnic groups. Ethn Health, 8, 71–82.
McKinnon, W. C., Baty, B. J., Bennett, R. L., Magee, M., Neufeld-Kaiser, W. A., Peters, K. F., et al. (1997). Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors. Jama, 278, 1217–1220.
Metcalfe, K., Lynch, H. T., Ghadirian, P., Tung, N., Olivotto, I., Warner, E., et al. (2004). Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol, 22, 2328–2335.
Metcalfe, K. A., Lynch, H. T., Ghadirian, P., Tung, N., Olivotto, I. A., Foulkes, W. D., et al. (2005). The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecol Oncol, 96, 222–226.
Meyerowitz, B. E., Richardson, J., Hudson, S., & Leedham, B. (1998). Ethnicity and cancer outcomes: behavioral and psychosocial considerations. Psychol Bull, 123, 47–70.
Narod, S. A., Brunet, J. S., Ghadirian, P., Robson, M., Heimdal, K., Neuhausen, S. L., et al. (2000). Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet, 356, 1876–1881.
Nedelcu, R., Blazer, K. R., Sand, S., Arbayo, C., Fuentes, S., Uman, G. C., et al. (2002, October 15–19, 2002). Genetic cancer risk assessment (GCRA) in an underserved setting: survey of needs, knowledge and concerns. Paper presented at the The American Society of Human Genetics 52 nd Annual Meeting, Baltimore, Maryland.
Olopade, O. (2004). Genetics in clinical cancer care: a promise unfulfilled among minority populations. Cancer Epidemiol Biomarkers Prev, 13, 1683–1686.
Palomares, M. R., Paz, I. B., & Weitzel, J. N. (2005). Genetic cancer risk assessment in the newly diagnosed breast cancer patient is useful and possible in practice. J Clin Oncol, 23, 3165–3166.
Penchaszadeh, V. B. (2001). Genetic counseling issues in Latinos. Genet Test, 5, 193–200.
Penchaszadeh, V. B., & Punales-Morejon, D. (1998). Genetic services to the latino population in the United States. Community Genet, 1, 134–141.
Peragallo, N. P., Fox, P. G., & Alba, M. L. (2000). Acculturation and breast self-examination among immigrant Latina women in the USA. Int Nurs Rev, 47, 38–45.
Perez-Stable, E. J., Sabogal, F., Otero-Sabogal, R., Hiatt, R. A., & McPhee, S. J. (1992). Misconceptions about cancer among Latinos and Anglos. Jama, 268, 3219–3223.
Registry, C. C. (2005). Female Breast Cancer in California, 2005.
Ricker, C. N., Hiyama, S., Fuentes, S., Feldman, N., Kumar, V., Uman, G. C., et al. (in press). Beliefs and interest in cancer risk in an underserved Latino cohort. Prev Med.
Robson, M., Svahn, T., McCormick, B., Borgen, P., Hudis, C. A., Norton, L., et al. (2005). Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: A clinic-based series. Cancer, 103, 44–51.
Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., et al. (2002). Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol, 20, 1260–1268.
Schwartz, M. D., Lerman, C., Brogan, B., Peshkin, B. N., Hughes Halbert, C., DeMarco, T., et al. (2004). Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol, 22, 1823–1829.
Shavers, V. L., Harlan, L. C., & Stevens, J. L. (2003). Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer, 97, 134–147.
Solis, J. M., Marks, G., Garcia, M., & Shelton, D. (1990). Acculturation, access to care, and use of preventive services by Hispanics: findings from HHANES 1982–84. Am J Public Health, 80 Suppl, 11–19.
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med, 336, 1401–1408.
Suarez, L., & Pulley, L. (1995). Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women. J Natl Cancer Inst Monogr, 18, 41–47.
Weitzel, J. N., Lagos, V., Blazer, K. R., Nelson, R., Ricker, C., Herzog, J., et al. (2005). Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev, 14, 1666–1671.
Weitzel, J. N., McCaffrey, S. M., Nedelcu, R., MacDonald, D. J., Blazer, K. R., & Cullinane, C. A. (2003). Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg, 138, 1323–1328; discussion 1329.
Wideroff, L., Vadaparampil, S. T., Breen, N., Croyle, R. T., & Freedman, A. N. (2003). Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genet, 6, 147–156.
Yarnall, K. S. H., Rimer, B. K., Hynes, D., Watson, G., Lyna, P. R., Woods-Powell, C. T., et al. (1998). Computerized prompts for cancer screening in a community health center. J Am Board Fam Pract, 11, 96–104.
Zaloznik, A. J. (1997). Breast cancer stage at diagnosis: Caucasians versus Hispanics. Breast Cancer Res Treat, 42, 121–124.
ACKNOWLEDGMENTS
The study was supported in part by California Cancer Research Program of the University of California grants 99-86874 and 00-92133 and by a General Clinical Research Center grant from NIH (M01 RR00043) awarded to the City of Hope Comprehensive Cancer Center, Duarte, California.
Author information
Authors and Affiliations
Corresponding author
Additional information
“Latino” is the most common census term for individuals of Spanish, Mexican, Central and South American, Cuban, or Puerto Rican descent, referring to ethnicity, and is generally considered a more ethnically/culturally based term for individuals of the aforementioned groups. As this cohort is female the feminine noun “Latina” is used
Rights and permissions
About this article
Cite this article
Ricker, C., Lagos, V., Feldman, N. et al. If We Build It … Will They Come? – Establishing a Cancer Genetics Services Clinic for an Underserved Predominantly Latina Cohort. J Genet Counsel 15, 505–514 (2006). https://doi.org/10.1007/s10897-006-9052-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-006-9052-5